BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37982578)

  • 1. The promoting effects of Grin2d expression in tumorigenesis and the aggressiveness of esophageal cancer.
    Wang LL; Li J; Xue H; Zhang L; Yu DY; Yang N; Yun WJ; Zhao MZ; Xue H
    Histol Histopathol; 2024 May; 39(5):659-670. PubMed ID: 37982578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRIN2D knockdown suppresses the progression of lung adenocarcinoma by regulating the E2F signalling pathway.
    Chen Z; Song Y; Li P; Gao W
    Cell Signal; 2023 Jul; 107():110685. PubMed ID: 37084840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53.
    Feith M; Stein HJ; Mueller J; Siewert JR
    Dis Esophagus; 2004; 17(4):322-7. PubMed ID: 15569371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The facilitating effects of KRT80 on chemoresistance, lipogenesis, and invasion of esophageal cancer.
    Yun WJ; Li J; Yin NC; Zhang CY; Cui ZG; Zhang L; Zheng HC
    Cancer Biol Ther; 2024 Dec; 25(1):2302162. PubMed ID: 38241178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways.
    Zhang LN; Zhao L; Yan XL; Huang YH
    J Cell Physiol; 2019 Nov; 234(11):20469-20484. PubMed ID: 30989663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
    Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
    Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of sine oculis homeobox homolog 3 is associated with proliferation, invasion, migration, as well as poor prognosis of esophageal cancer.
    Du J
    Anticancer Drugs; 2019 Jul; 30(6):596-603. PubMed ID: 30672777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin E involved in early stage carcinogenesis of esophageal adenocarcinoma by SNP DNA microarray and immunohistochemical studies.
    Zhou Z; Bandla S; Ye J; Xia Y; Que J; Luketich JD; Pennathur A; Peters JH; Tan D; Godfrey TE
    BMC Gastroenterol; 2014 Apr; 14():78. PubMed ID: 24742107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promoting effects of GPR176 expression on proliferation, chemoresistance, lipogenesis and invasion of oesophageal cancer.
    Yun WJ; Li J; Yin NC; Zhang CY; Cui ZG; Zhang L; Zheng HC
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14641-14655. PubMed ID: 37584712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancer.
    Du W; Gao A; Herman JG; Wang L; Zhang L; Jiao S; Guo M
    Cancer Sci; 2021 Jul; 112(7):2870-2883. PubMed ID: 33931924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
    Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
    J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 14. Notch Signaling Target Genes are Directly Correlated to Esophageal Squamous Cell Carcinoma Tumorigenesis.
    Forghanifard MM; Taleb S; Abbaszadegan MR
    Pathol Oncol Res; 2015 Apr; 21(2):463-7. PubMed ID: 25361534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-2053 involves in the progression of esophageal cancer by targeting KIF3C.
    Yao W; Jia X; Xu L; Li S; Wei L
    Cell Cycle; 2021 Jun; 20(12):1163-1172. PubMed ID: 34057012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircBIRC6 facilitates the malignant progression via miR-488/GRIN2D-mediated CAV1-autophagy signal axis in gastric cancer.
    Tang Z; Li J; Lu B; Zhang X; Yang L; Qi Y; Jiang S; Wu Q; Wang Y; Cheng T; Xu M; Sun P; Wang X; Miao K; Wu H; Huang J
    Pharmacol Res; 2024 Apr; 202():107127. PubMed ID: 38438090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
    Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-129-1-3p protects cardiomyocytes from pirarubicin-induced apoptosis by down-regulating the GRIN2D-mediated Ca
    Li Q; Qin M; Tan Q; Li T; Gu Z; Huang P; Ren L
    J Cell Mol Med; 2020 Feb; 24(3):2260-2271. PubMed ID: 31957170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer.
    Wu YR; Qi HJ; Deng DF; Luo YY; Yang SL
    Tumour Biol; 2016 Sep; 37(9):12061-12070. PubMed ID: 27188433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.
    Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM
    Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.